Every 8-K that Astrotech Corp (ASTC) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow ASTC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ASTC filings page.
Astrotech Corporation (ASTC) reported an update to its equity financing arrangements under its existing at-the-market offering agreement with H.C. Wainwright & Co., LLC. The company filed a new prospectus supplement under a recently effective shelf registration statement to permit the offer and sale of up to $50 million of common stock through at-the-market transactions, with Wainwright acting as sales agent. This new supplement replaces and supersedes the prior June 2026 prospectus supplement, under which Astrotech had been authorized to sell up to approximately $24.5 million of common stock. As of August 19, 2026, Astrotech had sold 258,856 shares of common stock for gross proceeds of approximately $7.9 million under the prior supplement, and no further sales will be made under that earlier document. A legal opinion from Haynes and Boone, LLP, covering the validity of the newly registered shares, is filed as an exhibit.
Astrotech Corporation expanded its Board of Directors and appointed Matt Kreps as a director, effective July 16, 2026. He will serve until the company’s 2026 annual meeting of stockholders and until a successor is elected and qualified or earlier departure. As of this appointment, he has not been assigned to any board committees.
Kreps, aged 49, brings more than 25 years of experience in capital markets and investor relations, including senior roles at HydroGraph Clean Power Inc. and Darrow Associates. Astrotech granted him 2,150 shares of restricted stock under its 2021 Omnibus Equity Incentive Plan, vesting in three equal annual installments. He will receive standard non-employee director compensation, and the company reports no related-party transactions or special arrangements tied to his appointment. A press release dated July 22, 2026 announced the move.
Astrotech Corporation’s board has authorized management to pursue a potential sale process for its 1st Detect Corporation subsidiary, which develops the TRACER 1000 explosives and narcotics trace detection platform. The company is evaluating a sale to raise additional capital for its previously announced lunar mining initiative.
The press release highlights multiple regulatory and operational milestones for TRACER 1000, including TSA and European certifications and a U.S. Department of Homeland Security development award, which management believes have increased 1st Detect’s strategic value. The company cautions that any sale is uncertain and subject to market, regulatory, and execution risks.
Astrotech Corporation entered into an at-the-market offering agreement that allows it to sell shares of its common stock with an aggregate offering price of up to $24,492,819 through H.C. Wainwright & Co., LLC. Sales may be made from time to time under the company’s effective Form S-3 shelf registration and a June 2, 2026 prospectus supplement.
Wainwright will act as sales agent and receive a 3.0% commission on the aggregate gross proceeds from each sale. Astrotech is not required to sell any shares, and the program will end when all authorized shares are sold or the agreement is terminated.
Astrotech Corporation reported third-quarter fiscal 2026 results for the period ended March 31, 2026. Revenue for the quarter was $343 thousand compared with $534 thousand a year earlier, generating gross profit of $67 thousand. Operating expenses were $3.52 million, leading to a loss from operations of $3.45 million and a quarterly net loss of $3.77 million, versus $3.63 million in the prior-year quarter.
For the nine months ended March 31, 2026, revenue totaled $787 thousand and net loss was $11.16 million. Cash and cash equivalents were $2.68 million and short-term investments were $3.90 million as of March 31, 2026. Total assets were $16.17 million and total stockholders’ equity was $12.16 million, with an accumulated deficit of $262.03 million. Management highlighted continued cost-efficiency efforts while investing selectively in higher-return areas and advancing a sales pipeline across industrial, safety and trace detection markets.
Astrotech Corporation reported results for its second quarter of fiscal 2026, which ended December 31, 2025. Revenue for the quarter was $148,000, down from $261,000 a year earlier, while the net loss narrowed slightly to $3.9 million from $4.0 million.
For the first six months of fiscal 2026, revenue rose to $445,000 from $295,000, but the net loss widened modestly to $7.4 million compared with $7.3 million in the prior-year period. As of December 31, 2025, Astrotech held $3.1 million in cash and cash equivalents and $7.0 million in short-term investments, with total stockholders’ equity of $15.5 million.
Astrotech Corporation extended the duration of its stockholder rights plan. On December 12, 2025, the company entered into Amendment No. 3 to its Rights Agreement with Equiniti Trust Company, moving the Final Expiration Date of the rights to 5:00 p.m. New York City time on December 20, 2026, unless the date is further extended or the rights are earlier redeemed or exchanged under the agreement. All other terms of the rights plan remain the same.
The company also held its annual stockholder meeting on December 12, 2025, with 969,211 of 1,769,269 common shares entitled to vote represented in person or by proxy. Stockholders elected all director nominees and ratified the appointment of RBSM LLP as the independent registered public accounting firm for the fiscal year ending June 30, 2026, with 935,627 votes for, 20,631 against, and 12,952 withheld.
Astrotech Corporation furnished a Form 8-K announcing results of operations for its first quarter of fiscal 2026, which ended September 30, 2025.
The press release is attached as Exhibit 99.1 and incorporated by reference; this information is furnished and not deemed filed under the Exchange Act.
Astrotech Corporation approved a Transaction Bonus Plan that pays designated participants a percentage of net proceeds from a future “qualifying transaction.” The Bonus Pool equals 10% of the first $50 million, 5% of amounts between $50 million and $100 million, and 2% of amounts above $100 million, and is only established if net proceeds reach at least $30 million.
Eligible participants (selected employees, contractors, or outside directors) must be actively providing services on the closing date, with bonuses paid in cash within 30 days after closing. If a participant has a “qualifying termination,” eligibility can continue if the transaction closes within six months. The plan is effective November 5, 2025 and runs until the earlier of five years or termination under its terms.
Astrotech also finalized separation terms with former CFO Jennifer Canas. She will receive a cash separation payment of $122,795.25, and the company will pay COBRA premiums for her and eligible dependents through April 30, 2026 or until other coverage begins, in exchange for a general release and customary covenants.
Astrotech Corporation appointed Scott Bartley as Interim Chief Financial Officer, Treasurer and Secretary. The Board’s appointment occurred on October 27, 2025, with services provided under a consulting arrangement.
Under a Consulting Services Agreement effective October 5, 2025, Mr. Bartley will be paid approximately $7,800 per week at $260 per hour for about 30 hours per week. Either party may terminate the agreement with two weeks’ written notice, and travel expenses are shared between Bridgepoint Consulting and the Company. The Company will use its standard indemnification agreement. Astrotech also issued a press release on October 31, 2025.
Astrotech Corporation announced that Jennifer Canas resigned as Chief Financial Officer, Treasurer and Secretary, effective immediately on October 17, 2025. The company reported her resignation under Item 5.02 of the Exchange Act.
Astrotech intends to negotiate a separation agreement with Ms. Canas that would outline certain separation benefits and include restrictive covenants in favor of the company. No additional management changes or financial details are included in this report.
Astrotech Corporation filed a current report stating that it has issued a press release announcing its results of operations for the quarter and year ended June 30, 2025.
The press release, dated September 25, 2025, is furnished as Exhibit 99.1 and is incorporated by reference in this report. The company notes that the information provided under this item, including Exhibit 99.1, is being furnished rather than filed, which means it is not automatically subject to certain Exchange Act liabilities or incorporated into other securities offerings unless specifically referenced.
Astrotech Corporation announced the appointment of Nihanth Badugu as Chief Operating Officer, effective August 13, 2025. Mr. Badugu, age 37, has served as the company’s Director of Program Management since August 2023 and previously held program and NPI management roles at Thermo Fisher Scientific and PVA Consulting Group. The Compensation Committee set his annual base salary at $225,000 and awarded 5,000 stock options with a strike price equal to the closing price on August 13, 2025; vesting will follow a schedule determined by the Committee tied to performance and retention. He is eligible for an annual performance bonus equal to 25% of base salary ($56,250), which is doubled if gross margin targets are met, with potential additional bonuses for outperformance. The filing states there are no related-party transactions or family relationships requiring disclosure.